Fund Holdings — RA CAPITAL MANAGEMENT, L.P.

Total Portfolio Value:
$5.94B
Total Bought:
$370.64M
Total Sold:
$659.69M
Net Transaction:
-$289.05M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Ascendis Pharma A/SSH(ASND)10,281,49610,281,4960$1.60B$1.77B29.90%+$172.11M
Vaxcyte, Inc.SH(PCVX)12,189,14911,965,991-223,158$460.26M$389.01M6.55%-$71.25M
Rhythm Pharmaceuticals, Inc.SH(RYTM)6,084,4125,561,359-523,053$322.29M$351.42M5.92%+$29.13M
Janux Therapeutics, Inc.SH(JANX)11,189,69311,189,6930$302.12M$258.48M4.35%-$43.64M
Avidity Biosciences IncSH6,300,4087,266,031+965,623$185.99M$206.36M3.48%+$20.37M
Arcellx IncSH
COMMON STOCK
3,036,5273,036,5270$199.20M$199.96M3.37%+$759.1K
89bio IncSH19,889,68319,889,6830$144.60M$195.32M3.29%+$50.72M
ARS Pharmaceuticals, Inc.SH(SPRY)10,860,97710,860,9770$136.63M$189.52M3.19%+$52.89M
Newamsterdam Pharma Co NvSH
ORDINARY SHARES
10,138,93810,138,9380$207.54M$183.62M3.09%-$23.93M
Sionna Therapeutics, Inc.SH(SION)10,445,32210,445,3220$109.26M$181.23M3.05%+$71.97M
Cidara Therapeutics IncSH1,092,7963,365,523+2,272,727$23.54M$163.93M2.76%+$140.40M
Edgewise Therapeutics, Inc.SH(EWTX)8,909,0919,902,633+993,542$196.00M$129.82M2.19%-$66.18M
LENZ Therapeutics, Inc.SH(LENZ)4,178,8234,178,8230$107.44M$122.48M2.06%+$15.04M
Wave Life Sciences, Inc.SH(WVE)18,202,00918,202,0090$147.07M$118.31M1.99%-$28.76M
Tyra Biosciences, Inc.SH(TYRA)10,637,29012,198,625+1,561,335$98.93M$116.74M1.97%+$17.81M
GH Research PLCSH(GHRS)6,944,6487,676,697+732,049$76.60M$93.58M1.58%+$16.98M
Dyne Therapeutics, Inc.SH(DYN)9,714,3929,714,3920$101.61M$92.48M1.56%-$9.13M
Geron CorporationSH(GERN)60,379,36660,379,3660$96.00M$85.13M1.43%-$10.87M
Disc Medicine, Inc.SH(IRON)1,577,1061,577,1060$78.29M$83.52M1.41%+$5.24M
Mineralys Therapeutics, Inc.SH(MLYS)6,147,2806,147,2800$97.62M$83.17M1.40%-$14.45M
Septerna, Inc.SH(SEPN)6,995,8586,995,8580$40.51M$73.95M1.25%+$33.44M
Fulcrum Therapeutics, Inc.SH(FULC)10,229,09910,229,0990$29.46M$70.38M1.19%+$40.92M
Bicara Therapeutics IncSH6,955,9936,955,9930$90.64M$64.62M1.09%-$26.02M
Vor Biopharma Inc.SH(VOR)39,646,03939,646,0390$28.45M$64.23M1.08%+$35.78M
Taysha Gene Therapies, Inc.SH(TSHA)10,872,50323,555,648+12,683,145$15.11M$54.41M0.92%+$39.30M
Dianthus Therapeutics, Inc.SH(DNTH)2,866,7332,866,7330$52.00M$53.41M0.90%+$1.40M
RxSight, Inc.SH(RXST)3,743,0183,702,967-40,051$94.51M$48.14M0.81%-$46.37M
Tourmaline Bio IncSH2,538,9252,538,9250$38.62M$40.60M0.68%+$1.98M
Scholar Rock Holding CorporationSH(SRRK)1,136,4531,136,4530$36.54M$40.25M0.68%+$3.72M
Climb Bio, Inc.SH(CLYM)31,419,26731,419,2670$38.33M$38.96M0.66%+$628.4K
Structure Therapeutics IncSH1,517,4181,517,4180$26.27M$31.47M0.53%+$5.20M
Solid Biosciences IncSH4,330,4465,811,323+1,480,877$16.02M$28.30M0.48%+$12.28M
Metsera IncSH675,525675,5250$18.39M$19.22M0.32%+$830.9K
Monopar Therapeutics Inc.SH(MNPR)511,207511,2070$18.61M$18.29M0.31%-$322.1K
Nkarta, Inc.SH(NKTX)10,805,12910,805,1290$19.88M$17.94M0.30%-$1.94M
Larimar Therapeutics, Inc.SH(LRMR)6,045,3516,045,3510$13.00M$17.47M0.29%+$4.47M
Acumen Pharmaceuticals, Inc.SH(ABOS)14,932,06314,932,0630$16.43M$17.32M0.29%+$895.9K
Enliven Therapeutics IncSH848,986848,9860$16.71M$17.03M0.29%+$322.6K
Travere Therapeutics, Inc.SH(TVTX)1,150,0001,150,0000$20.61M$17.02M0.29%-$3.59M
4d Molecular Therapeutics InSH4,563,2114,563,2110$14.74M$16.93M0.29%+$2.19M
Hinge Health, Inc.SH(HNGE)0300,000+300,000$0$15.53M0.26%+$15.53M
Artiva Biotherapeutics, Inc.SH(ARTV)9,853,3029,853,3020$29.56M$14.88M0.25%-$14.68M
PepGen Inc.SH(PEPG)10,689,54510,689,5450$15.02M$11.87M0.20%-$3.15M
Jade Biosciences IncSH01,062,326+1,062,326$0$10.61M0.18%+$10.61M
Tango Therapeutics, Inc.SH(TNGX)02,000,000+2,000,000$0$10.24M0.17%+$10.24M
Acrivon Therapeutics IncSH8,340,5088,340,5080$16.93M$9.93M0.17%-$7.01M
Eledon Pharmaceuticals, Inc.SH(ELDN)3,566,3383,566,3380$12.09M$9.66M0.16%-$2.43M
Arcus Biosciences, Inc.SH(RCUS)1,136,3641,136,3640$8.92M$9.25M0.16%+$329.5K
Perceptive Capital SolutionsSH
CL A ORD SHS
750,000750,0000$7.72M$7.96M0.13%+$240.0K
Omada Health, Inc.SH(OMDA)0400,000+400,000$0$7.32M0.12%+$7.32M
Werewolf Therapeutics, Inc.SH(HOWL)6,144,8816,681,307+536,426$5.97M$7.28M0.12%+$1.31M
Beta Bionics, Inc.SH(BBNX)500,000500,0000$6.12M$7.28M0.12%+$1.16M
CytomX Therapeutics, Inc.SH(CTMX)1,000,0002,661,331+1,661,331$635.8K$6.04M0.10%+$5.41M
10x Genomics, Inc.SH(TXG)1,944,247475,343-1,468,904$16.97M$5.50M0.09%-$11.47M
Surrozen, Inc.SH(SRZN)679,130602,626-76,504$7.92M$5.39M0.09%-$2.53M
GeneDx Holdings Corp.SH(WGS)058,044+58,044$0$5.36M0.09%+$5.36M
Avalo Therapeutics, Inc.SH(AVTX)967,000932,973-34,027$7.75M$4.66M0.08%-$3.09M
Adicet Bio IncSH7,541,0007,541,0000$5.69M$4.60M0.08%-$1.09M
MBX Biosciences, Inc.SH(MBX)1,511,334377,841-1,133,493$11.15M$4.31M0.07%-$6.84M
Protara Therapeutics, Inc.SH(TARA)3,400,0001,039,295-2,360,705$14.48M$3.15M0.05%-$11.33M
Newamsterdam Pharma Co Nv-27SH
*W EXP 99/99/999
333,333333,3330$3.00M$2.67M0.04%-$330.0K
Acadia Healthcare Company, Inc.SH(ACHC)217,00089,262-127,738$6.58M$2.03M0.03%-$4.55M
InflaRx N.V.SH(IFRX)01,973,233+1,973,233$0$1.56M0.03%+$1.56M
Alector IncSH9,695,2280-9,695,228$11.93M$0—-$11.93M
Apogee Therapeutics IncSH1,569,4910-1,569,491$58.64M$0—-$58.64M
Astria Therapeutics IncSH5,105,2130-5,105,213$27.26M$0—-$27.26M
Aerovate Therapeutics IncSH9,192,0920-9,192,092$23.07M$0—-$23.07M
Bicycle Therapeutics Plc-AdrSH1,093,4770-1,093,477$9.28M$0—-$9.28M
Boundless Bio, Inc.SH(BOLD)2,180,6310-2,180,631$3.29M$0—-$3.29M
Day One Biopharmaceuticals ISH
COM
5,755,5770-5,755,577$45.64M$0—-$45.64M
EyePoint, Inc.SH(EYPT)3,181,8180-3,181,818$17.25M$0—-$17.25M
IDEAYA Biosciences, Inc.SH(IDYA)1,347,2520-1,347,252$22.07M$0—-$22.07M
Immatics N.V.SH(IMTX)1,750,0000-1,750,000$7.89M$0—-$7.89M
Insmed IncorporatedSH(INSM)200,0000-200,000$15.26M$0—-$15.26M
Iteos Therapeutics IncSH3,649,0570-3,649,057$21.78M$0—-$21.78M
Kura Oncology, Inc.SH(KURA)4,004,6100-4,004,610$26.43M$0—-$26.43M
Lexeo Therapeutics, Inc.SH(LXEO)546,5540-546,554$1.90M$0—-$1.90M
Nurix Therapeutics, Inc.SH(NRIX)1,333,3330-1,333,333$15.84M$0—-$15.84M
Scilex Holding CompanySH(SCLX)1,036,2180-1,036,218$257.5K$0—-$257.5K
Sera Prognostics, Inc.SH(SERA)3,032,8080-3,032,808$11.16M$0—-$11.16M
Xencor, Inc.SH(XNCR)575,0000-575,000$6.12M$0—-$6.12M
Zai Lab LimitedSH(ZLAB)1,295,0400-1,295,040$46.80M$0—-$46.80M
Zura Bio LimitedSH(ZURA)3,217,5030-3,217,503$4.15M$0—-$4.15M
Bright Minds Biosciences Inc.SH(DRUG)206,4270-206,427$7.45M$0—-$7.45M
Aclaris Therapeutics, Inc.SH(ACRS)4,666,6670-4,666,667$7.14M$0—-$7.14M
CeriBell, Inc.SH(CBLL)824,5820-824,582$15.84M$0—-$15.84M
BioAge Labs, Inc.SH(BIOA)1,052,4940-1,052,494$3.96M$0—-$3.96M
UroGen Pharma Ltd.SH(URGN)3,206,2710-3,206,271$35.46M$0—-$35.46M
Humacyte, Inc.SH(HUMA)3,312,3560-3,312,356$5.65M$0—-$5.65M
Glaukos CorporationSH(GKOS)190,2560-190,256$18.72M$0—-$18.72M
Sutro Biopharma, Inc.SH(STRO)4,434,6370-4,434,637$2.89M$0—-$2.89M
Page 1 of 1
RA CAPITAL MANAGEMENT, L.P. — 13F Holdings — Q2 2025 | TickerTrail